Key result
Higher admission monocyte count was an independent predictor of angiographic no-reflow after primary PCI in patients with STEMI (OR 2.665; 95% CI 1.102-6.445; p=0.030).
Why the study?
Does admission monocyte count predict angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI?
Population
236 patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous…
Design
Cohort
Authors
Loading...
Should not change STEMI management; hypothesis-generating for monocyte-based risk stratification or therapies.
Observational (n=236)
Does admission monocyte count predict angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI?
Odds Ratio: 2.665 (95% CI 1.102–6.445)
p-value: p=0.030
Higher admission monocyte count and lower hemoglobin concentration are independent predictors of angiographic no-reflow following primary PCI in STEMI patients.
Wang et al. (2016) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=236). Admission monocyte count was evaluated on Angiographic no-reflow (TIMI flow grade ≤ 2) (OR 2.665, 95% CI 1.102-6.445, p=0.030). Higher admission monocyte count was an independent predictor of angiographic no-reflow after primary PCI in patients with STEMI (OR 2.665; 95% CI 1.102-6.445; p=0.030).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: